Last reviewed · How we verify

NCT05914350

Comparison Between Ultrasound Guided Ozone, Platelet-Rich Plasma or Steroid Injection in the Treatment of Sacroiliitis; a Randomized Double Blinded Controlled Study

Status unknown NA Last updated 22 June 2023
What this trial tests

NA trial testing ultrasound guided Ozone, platelet-rich plasma or steroid injection in the treatment of sacroiliitis in the Efficacy of Ultrasound Guided Sacroiliac Injection of Ozone, Platelet Rich Plasma (PRP) or Steroid for Treatment of Sacroiliitis in 105 participants. Status unknown.

Timeline
23 June 2023
Primary endpoint
23 March 2025
23 March 2025

Quick facts

Lead sponsorTanta University
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposesupportive care
Enrollment105
Start date23 June 2023
Primary completion23 March 2025
Estimated completion23 March 2025
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Tanta University

Who can join

Adults 21 to 65, any sex, with the Efficacy of Ultrasound Guided Sacroiliac Injection of Ozone, Platelet Rich Plasma (PRP) or Steroid for Treatment of Sacroiliitis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Comparison between ultrasound guided Ozone, platelet-rich plasma or steroid injection in the treatment of sacroiliitis; a Randomized Double Blinded Controlled Study

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Tanta University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05914350.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing